Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Mohamed Hamouda, Mohamed Farghaly & Sara Al Dallal. (2023) Budget Impact Analysis of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Asthma in the Dubai Academic Healthcare Corporation. ClinicoEconomics and Outcomes Research 15, pages 549-558.
Read now
Read now
Michael Asamoah-Boaheng, Jamie Farrell, Kwadwo Osei Bonsu, Alwell Oyet & William K Midodzi. (2022) Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada. Clinical Epidemiology 14, pages 1241-1254.
Read now
Read now
Michael Asamoah-Boaheng, Jamie Farrell, Kwadwo Osei Bonsu & William K. Midodzi,. (2022) Determining the optimal threshold for medication adherence in adult asthma patients: an analysis of British Columbia administrative health database in Canada. Journal of Asthma 59:12, pages 2449-2460.
Read now
Read now
Carlyne M. Averell, François Laliberté, Guillaume Germain, Mei Sheng Duh, Robson Lima, Malena Mahendran & David J. Slade. (2022) Symptom control in patients with asthma using inhaled corticosteroids/long-acting β2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study. Journal of Asthma 59:9, pages 1805-1818.
Read now
Read now
Carlyne M. Averell, François Laliberté, Guillaume Germain, David J. Slade, Mei S. Duh & Joseph Spahn. (2022) Disease burden and treatment adherence among children and adolescent patients with asthma. Journal of Asthma 59:8, pages 1687-1696.
Read now
Read now
Rajesh Venkitakrishnan, MD, dnb, Prasanna Kumar Thomas, MD, Ankit Bansal, MD, dnb, Indranath Ghosh, MD, Jolsana Augustine, dtcd, dnb, R. Divya, md & Melcy Cleetus, dtcd, dnb. (2022) Fluticasone/formoterol compared with other ICS/LABAs in asthma: a systematic review. Journal of Asthma 59:6, pages 1221-1230.
Read now
Read now
Corrado Pelaia, Claudia Crimi, Nunzio Crimi, Luisa Ricciardi, Nicola Scichilone, Giuseppe Valenti, Ornella Bonavita, Stefano Andaloro, Paolo Morini, Andrea Rizzi & Girolamo Pelaia. (2022) Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma. Expert Review of Respiratory Medicine 16:2, pages 183-195.
Read now
Read now
Michael Asamoah-Boaheng, Kwadwo Osei Bonsu, Jamie Farrell, Alwell Oyet & William K Midodzi. (2021) Measuring Medication Adherence in a Population-Based Asthma Administrative Pharmacy Database: A Systematic Review and Meta-Analysis. Clinical Epidemiology 13, pages 981-1010.
Read now
Read now
Carlyne M. Averell, Richard H. Stanford, François Laliberté, Jennifer W. Wu, Guillaume Germain & Mei Sheng Duh. (2021) Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs. Journal of Asthma 58:1, pages 102-111.
Read now
Read now
Bunchai Chongmelaxme, Nathorn Chaiyakunapruk & Piyameth Dilokthornsakul. (2019) Incorporating adherence in cost-effectiveness analyses of asthma: a systematic review. Journal of Medical Economics 22:6, pages 554-566.
Read now
Read now
Ilaria Baiardini, Silviya Novakova, Stefan Mihaicuta, Ipek Kivilcim Oguzulgen & Giorgio Walter Canonica. (2019) Adherence to treatment in allergic respiratory diseases. Expert Review of Respiratory Medicine 13:1, pages 53-62.
Read now
Read now
A. Ismaila, D. Corriveau, J. Vaillancourt, D. Parsons, R. Stanford, Z. Su & J. S. Sampalis. (2014) Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Current Medical Research and Opinion 30:7, pages 1417-1425.
Read now
Read now
Rachel Halpern, Christine L Baker, Jun Su, Kimberly B Woodruff, Ryne Paulose-Ram, Victoria Porter & Hemal Shah. (2011) Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease. Patient Preference and Adherence 5, pages 375-388.
Read now
Read now
Andrew P. Yu, Hongbo Yang, Eric Q. Wu, Juliana Setyawan, Michelle Mocarski & Steven Blum. (2011) Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis. Journal of Medical Economics 14:3, pages 315-323.
Read now
Read now
Articles from other publishers (34)
Johannes Wendl, Andreas Simon, Martin Kistler, Jana Hapfelmeier, Antonius Schneider & Alexander Hapfelmeier. (2023) Medication Adherence and Healthcare Costs in Chronically Ill Patients Using German Claims Data. Applied Health Economics and Health Policy 21:3, pages 477-487.
Crossref
Crossref
William W. Busse, Carl B. Abbott, Guillaume Germain, François Laliberté, Sean D. MacKnight, Young Jung, Mei Sheng Duh & Carlyne M. Averell. (2022) Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management. The Journal of Allergy and Clinical Immunology: In Practice 10:11, pages 2904-2913.e6.
Crossref
Crossref
G. Jébrak, V. Houdouin, P. Terrioux, N. Lambert, B. Maitre & A.-M. Ruppert. (2022) Observance thérapeutique dans l’asthme : variation selon les classes d’âge. Comment l’améliorer ? Apport des nouvelles technologies. Revue des Maladies Respiratoires 39:5, pages 442-454.
Crossref
Crossref
Zhong Wang, Sharon K. Ahluwalia, Bryan Newman, Sneha Dhapare, Liang Zhao & Markham C. Luke. (2022) Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USA. Therapeutic Innovation & Regulatory Science 56:2, pages 346-357.
Crossref
Crossref
Carlyne M. Averell, François Laliberté, Guillaume Germain, Mei Sheng Duh, Matthew D. Rousculp, Sean D. MacKnight & David J. Slade. (2022) Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States. Therapeutic Advances in Respiratory Disease 16, pages 175346662211169.
Crossref
Crossref
Dong-Wook Kim & Kwon Yeon Weon. (2021) Pharmaceutical application and development of fixed-dose combination: dosage form review. Journal of Pharmaceutical Investigation 51:5, pages 555-570.
Crossref
Crossref
Elizabeth J. Unni, Shaloo Gupta & Nikoletta Sternbach. (2021) Using the Medication Adherence Reasons Scale (MAR-Scale) in asthma and chronic obstructive pulmonary disease to determine the extent and identify the reasons for non-adherence. Respiratory Medicine 179, pages 106337.
Crossref
Crossref
Elliot Israel, Juan Carlos Cardet, Jennifer K. Carroll, Anne L. Fuhlbrigge, Wilson D. Pace, Nancy E. Maher, Lilin She, Frank W. Rockhold, Maureen Fagan, Victoria E. Forth, Paulina Arias Hernandez, Brian K. Manning, Jacqueline Rodriguez-Louis, Joel B. Shields, Tamera Coyne-Beasley, Barbara M. Kaplan, Cynthia S. Rand, Wilfredo Morales-Cosme, Michael E. Wechsler, Juan P. Wisnivesky, Mary White, Barbara P. Yawn, M. Diane McKee, Paula J. Busse, David C. Kaelber, Sylvette Nazario, Michelle L. Hernandez, Andrea J. Apter, Ku-Lang Chang, Victor Pinto-Plata, Paul M. Stranges, Laura P. Hurley, Jennifer Trevor, Thomas B. Casale, Geoffrey Chupp, Isaretta L. Riley, Kartik Shenoy, Magdalena Pasarica, Rafael A. Calderon-Candelario, Hazel Tapp & Ahmet Baydur. (2021) A randomized, open-label, pragmatic study to assess reliever-triggered inhaled corticosteroid in African American/Black and Hispanic/Latinx adults with asthma: Design and methods of the PREPARE trial. Contemporary Clinical Trials 101, pages 106246.
Crossref
Crossref
Ronit Hadad, Diana Likhtenshtein, Nimrod Maimon & Tzahit Simon-Tuval. (2020) Overuse of reliever inhalers and associated healthcare utilization of asthma patients. Scientific Reports 10:1.
Crossref
Crossref
V. Rajesh, Jolsana Augustine, R. Divya & Melcy Cleetus. (2020) Inhaled Formoterol-Fluticasone Single Inhaler Therapy in Asthma: Real-World Efficacy, Budget Impact, and Potential to Improve Adherence. Canadian Respiratory Journal 2020, pages 1-8.
Crossref
Crossref
Bunchai Chongmelaxme, Nathorn Chaiyakunapruk & Piyameth Dilokthornsakul. (2020) Association between adherence and severe asthma exacerbation: A systematic review and meta-analysis. Journal of the American Pharmacists Association 60:5, pages 669-685.e2.
Crossref
Crossref
Eleonore Fröhlich. (2019) Biological Obstacles for Identifying In Vitro-In Vivo Correlations of Orally Inhaled Formulations. Pharmaceutics 11:7, pages 316.
Crossref
Crossref
Johnny McNulty, Richard B. Reilly, Terence E. Taylor, Susan M. O'Dwyer, Richard W. Costello & Yaniv Zigel. (2019) Automatic Audio-Based Classification of Patient Inhaler Use: A Pharmacy Based Study. Automatic Audio-Based Classification of Patient Inhaler Use: A Pharmacy Based Study.
Richard H. Stanford, Carlyne Averell, Emily D. Parker, Cori Blauer-Peterson, Tyler K. Reinsch & Ami R. Buikema. (2019) Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma. The Journal of Allergy and Clinical Immunology: In Practice 7:5, pages 1488-1496.e7.
Crossref
Crossref
Ryo Atsuta, Jun Takai, Isao Mukai, Akihiro Kobayashi, Takeo Ishii & Henrik Svedsater. (2018) Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database. Pulmonary Therapy 4:2, pages 135-147.
Crossref
Crossref
Tatiana Makhinova, Jamie C. Barner, Carolyn M. Brown, Kristin M. Richards, Karen L. Rascati, J. Nile Barnes & Arpita Nag. (2018) Adherence enhancement for patients with asthma in community pharmacy practice: tools development and pharmacists’ feedback. Journal of Pharmaceutical Health Services Research 9:3, pages 215-226.
Crossref
Crossref
Mina Nicola, Ahmed A. Elberry, Ossama M. Sayed, Raghda R.S. Hussein & Mohamed E.A. Abdelrahim. (2018) Effect of DPI's training-device on inhalation technique and clinical efficacy in asthmatics. Beni-Suef University Journal of Basic and Applied Sciences 7:2, pages 178-183.
Crossref
Crossref
Rajan Merchant, Stanley J. Szefler, Bruce G. Bender, Michael Tuffli, Meredith A. Barrett, Rahul Gondalia, Leanne Kaye, David Van Sickle & David A. Stempel. (2018) Impact of a digital health intervention on asthma resource utilization. World Allergy Organization Journal 11, pages 28.
Crossref
Crossref
Laurent Laforest, Manon Belhassen, Gilles Devouassoux, Alain Didier, Marine Ginoux & Eric Van Ganse. (2016) Long-Term Inhaled Corticosteroid Adherence in Asthma Patients with Short-Term Adherence. The Journal of Allergy and Clinical Immunology: In Practice 4:5, pages 890-899.e2.
Crossref
Crossref
Tatiana Makhinova, Jamie C. Barner, Kristin M. Richards & Karen L. Rascati. (2015) Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma. Journal of Managed Care & Specialty Pharmacy 21:12, pages 1124-1132.
Crossref
Crossref
Richard H. Stanford, Saurabh Nagar, Xiwu Lin & Richard D. O'Connor. (2015) Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group. Journal of Managed Care & Specialty Pharmacy 21:11, pages 1014-1019.
Crossref
Crossref
Marjolein Engelkes, Hettie M. Janssens, Johan C. de Jongste, Miriam C.J.M. Sturkenboom & Katia M.C. Verhamme. (2015) Medication adherence and the risk of severe asthma exacerbations: a systematic review. European Respiratory Journal 45:2, pages 396-407.
Crossref
Crossref
Claudio F Donner & Alberto Visconti. (2014) AIMAR survey on complex forms of bronchial asthma and COPD, their management and perception of critical issues. Multidisciplinary Respiratory Medicine 9:1.
Crossref
Crossref
Michael Schatz, Lisa M. Meckley, Micheline Kim, Benjamin T. Stockwell & Mario Castro. (2014) Asthma Exacerbation Rates in Adults Are Unchanged Over a 5-Year Period Despite High-Intensity Therapy. The Journal of Allergy and Clinical Immunology: In Practice 2:5, pages 570-574.e1.
Crossref
Crossref
Mika J. Mäkelä, Vibeke Backer, Morten Hedegaard & Kjell Larsson. (2013) Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respiratory Medicine 107:10, pages 1481-1490.
Crossref
Crossref
Adel H. MansurKirsten Kaiser. (2013) Long-Term Safety and Efficacy of Fluticasone/Formoterol Combination Therapy in Asthma. Journal of Aerosol Medicine and Pulmonary Drug Delivery 26:4, pages 190-199.
Crossref
Crossref
David S. Pearlman, Craig F. LaForce & Kirsten Kaiser. (2013) Fluticasone/Formoterol Combination Therapy Compared With Monotherapy in Adolescent and Adult Patients With Mild to Moderate Asthma. Clinical Therapeutics 35:7, pages 950-966.
Crossref
Crossref
Jonathan Corren, Lyndon E. Mansfield, Tetyana Pertseva, Viktor Blahzko & Kirsten Kaiser. (2013) Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma. Respiratory Medicine 107:2, pages 180-195.
Crossref
Crossref
Sanjeeva Dissanayake, Birgit Grothe & Kirsten Kaiser. (2012) Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma. Respiratory Medicine 106, pages S20-S28.
Crossref
Crossref
Alberto Papi. (2012) A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice?. Respiratory Medicine 106, pages S1-S3.
Crossref
Crossref
Nargues A. WeirStewart J. Levine. (2011) Achieving Symptom Control in Patients with Moderate Asthma. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 6, pages CCRPM.S5100.
Crossref
Crossref
Anna Bodzenta-Lukaszyk, Grażyna Pulka, Andrzej Dymek, Dragos Bumbacea, Tammy McIver, Birgit Schwab & Heikki Mansikka. (2011) Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. Respiratory Medicine 105:5, pages 674-682.
Crossref
Crossref
Emmanuelle M. Clerisme-Beaty, Susan J. Bartlett, W. Gerald Teague, John Lima, Charles G. Irvin, Rubin Cohen, Mario Castro, Robert A. Wise & Cynthia S. Rand. (2011) The Madison Avenue effect: How drug presentation style influences adherence and outcome in patients with asthma. Journal of Allergy and Clinical Immunology 127:2, pages 406-411.
Crossref
Crossref
Jacyntha Sterling. (2009) Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy. Hospital Pharmacy 44:2, pages 193-199.
Crossref
Crossref